Efficacy Results from an Open-Label Safety Study of Galcanezumab in Patients with Episodic or Chronic Cluster Headache

被引：0
|
作者：
Gaul, C. [1 ]
Riesenberg, R. [2 ]
Stroud, C. [3 ]
Dong, Y. [3 ]
Oakes, T. Myers [3 ]
机构：
[1] Headache Ctr, Frankfurt, Germany
[2] Atlanta Ctr Med Res, Atlanta, GA USA
[3] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
CEPHALALGIA | 2021年 / 41卷 / 1_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
AL076
引用
收藏
页码：234 / 235
页数：2
相关论文
共 50 条
  • [31] Efficacy and safety of efalizumab for nail psoriasis: Results of an open-label, multicenter study
    Rich, Phoebe
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) : AB130 - AB130
  • [32] Sphenopalatine ganglion stimulation for cluster headache, results from a large, open-label European registry
    Mads Barloese
    Anja Petersen
    Philipp Stude
    Tim Jürgens
    Rigmor Højland Jensen
    Arne May
    The Journal of Headache and Pain, 2018, 19
  • [33] Efficacy and Safety of Ustekinumab for Chronic Pouchitis: A Prospective Open-label Multicenter Study
    Outtier, An
    Louis, Edouard
    Dewit, Olivier
    Reenaers, Catherine
    Schops, Ganel
    Lenfant, Matthias
    Pontus, Emilie
    De Hertogh, Gert
    Verstockt, Bram
    Sabino, Joao
    Vermeire, Severine
    Ferrante, Marc
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (12)
  • [34] Sphenopalatine ganglion stimulation for cluster headache, results from a large, open-label European registry
    Barloese, Mads
    Petersen, Anja
    Stude, Philipp
    Juergens, Tim
    Jensen, Rigmor Hojland
    May, Arne
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [35] Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study
    Tepper, Stewart J.
    Ashina, Messoud
    Reuter, Uwe
    Brandes, Jan Lewis
    Dolezil, David
    Silberstein, Stephen D.
    Winner, Paul
    Zhang, Feng
    Cheng, Sunfa
    Mikol, Daniel D.
    CEPHALALGIA, 2020, 40 (06) : 543 - 553
  • [36] Nefazodone for chronic daily headache prophylaxis: An open-label study
    Saper, JR
    Lake, AE
    Tepper, SJ
    HEADACHE, 2001, 41 (05): : 465 - 474
  • [37] Consistent efficacy and safety of erenumab in episodic migraine patients during a 5-year, open-label extension study
    Ashina, M.
    Goadsby, P.
    Reuter, U.
    Silberstein, S.
    Dodick, D.
    Zhang, F.
    Xue, F.
    Cheng, S.
    Chou, D.
    Lima, G. Paiva da Silva
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 153 - 154
  • [38] Prophylaxis therapy of the episodic and chronic cluster headache with zonisamide: an open study
    Pizza, V.
    Busillo, V.
    JOURNAL OF HEADACHE AND PAIN, 2010, 11 : S68 - S69
  • [39] EFFICACY AND SAFETY OF INTRAVENOUS GOLIMUMAB IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM A PHASE 3 OPEN-LABEL STUDY
    Ruperto, Nicolino
    Spindler, Alberto
    Pacheco Tena, Cesar Francisco
    Louw, Ingrid
    Vega Cornejo, Gabriel
    Kingsbury, Daniel
    Clark, Michael
    Bensley, Karen
    Li Xiaoming
    Brunner, Hermine
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 966 - 966
  • [40] EFFICACY AND SAFETY OF INTRAVENOUS GOLIMUMAB IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM A PHASE 3 OPEN-LABEL STUDY
    Spindler, Alberto
    Ruperto, Nicola
    Pacheco Tena, Cesar Francisco
    Louw, Ingrid
    Vega-Cornejo, Gabriel
    Kingsbury, Daniel
    Clark, Michael
    Bensley, Karen
    Li, Xiaoming
    Brunner, Hermine
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S11 - S11
12345